• Home
  • pagina de inicio
  • Contact
  • iTREAT Study Details
  • Team Updates
  • Participate
  • More
    • Home
    • pagina de inicio
    • Contact
    • iTREAT Study Details
    • Team Updates
    • Participate
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • pagina de inicio
  • Contact
  • iTREAT Study Details
  • Team Updates
  • Participate

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Ready to participate?

Find out if you qualify and join the study today. 

Get Started

iTREAT Study is looking to prevent asthma attacks

Get Involved

Treatment Groups

Treatment Groups

Looking to join the iTREAT Asthma study? Find out more here.

Participant Info

Treatment Groups

Treatment Groups

Treatment Groups

More about the study

Study Details

Current Updates

Treatment Groups

Current Updates

Full study is funded! See what we've been up to.

Updates

New ways to take old medicines may help asthma symptoms

What is iTREAT?

More about iTREAT:

More about iTREAT:

The iTREAT asthma study will compare different asthma treatments: a pill or adding a second inhaler to see if they reduce the need for emergency care or going to the hospital.  


Every patient will be given online asthma symptom tracking tools that have been shown to help manage asthma symptoms. 


  • Some participants will use a second inhaled medicine with their regular rescue or quick relief medicine. 
  • Some will start taking an antibiotic pill. 
  • Some will use both. The groups are assigned by chance, like a flip of a coin.  

More about iTREAT:

More about iTREAT:

More about iTREAT:

The study will be a four-arm study with 3,200 people.  Study arms will be rescue ICS (use of inhaled corticosteroids as part of rescue therapy), azithromycin therapy, rescue ICS plus azithromycin, or control.  


All participants will record their asthma symptoms using online tools. 


The  primary outcome will be yearly asthma exacerbation rates compared across the three intervention arms to the control arm. Secondary outcomes will be asthma control and asthma quality of life.  

More details

Connect with iTREAT and DARTNet Institute

Copyright © 2026 DARTNet Institute - All Rights Reserved. 

Derechos de autor © 2026 DARTNet Institute - Todos los derechos reservados.

Powered by

  • Contáctenos
  • Detalles sobre el estudio
  • participar
  • Actualizaciones
  • Practice Resources

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept